首页> 外国专利> Drug therapies for sustained release include estrogen microparticles and progesterone used in hormone replacement therapy for female mammals, as well as a surfactant, an isomerizer, a sticker and one or more preservatives.

Drug therapies for sustained release include estrogen microparticles and progesterone used in hormone replacement therapy for female mammals, as well as a surfactant, an isomerizer, a sticker and one or more preservatives.

机译:持续释放的药物疗法包括用于雌性哺乳动物的激素替代疗法中的雌激素微粒和孕酮,以及表面活性剂,异构体,粘贴剂和一种或多种防腐剂。

摘要

p Parenteral pharmaceutical formulation in sustained release suspension containing suspended particles of estradiol and progesterone, a surfactant, an isosmoacute; agent, a viscous agent and a conservative one or maacute; s , useful as a hormone replacement therapy. /p
机译:>持续释放悬浮液中的肠胃外药物制剂,其包含雌二醇和孕酮,表面活性剂,等渗的悬浮颗粒;剂,粘性剂和保守剂或maacute; s,用作激素替代疗法。

著录项

  • 公开/公告号CL2012001516A1

    专利类型

  • 公开/公告日2012-12-21

    原文格式PDF

  • 申请/专利权人 TECHSPHERE S.A. DE C.V.;

    申请/专利号CL20120001516

  • 申请日2012-06-08

  • 分类号A61K31/565;A61K31/57;A61K9/16;A61P5/30;A61P5/34;

  • 国家 CL

  • 入库时间 2022-08-21 16:42:11

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号